"MetaVia OXM analogue agonist meets endpoints in Phase Ib weight loss trial" was originally created and published by Clinical ...

MetaVia has shared an update on its attempt to crash the obesity party, reporting average weight loss of 9.1% in people who ...

A large population-based study found that adults with type 2 diabetes (T2D) who start treatment with sodium–glucose ...

Breakthrough Therapy Designation is intended to expedite the development and review of medicines that are intended to treat a serious or life-threatening condition and have shown preliminary clinical ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients prescribed glucagon-like peptide-1 agonists had ...

Overview: Glucagon is commonly used to increase blood sugar levels in people with dangerously low levels. It can also be used during certain tests to slow down gut movement. Common side effects may ...

A glucagon injection kit is used to treat episodes of severe hypoglycemia , where a patient is either unable to treat themselves or treatment by mouth has not been successful. Glucagon is a hormone ...

Severe hypoglycemia (low blood sugar) can cause people with diabetes to have seizures or lose consciousness, which can make it impossible to treat low blood sugar by eating or drinking something ...

At that point, the glucagon is released into the body. The researchers tested the device by implanting it in diabetic mice, and found that it helped bring their blood sugar levels back to normal ...

The US Food and Drug Administration has approved the first-ever generic glucagon injection kit for the treatment of severe hypoglycemia in patients with diabetes and as a diagnostic aid. The FDA ...